In clinical trial results released in December 2025, people on the highest dose of retatrutide lost nearly 30 percent of their body weight in 68 weeks
The consequent impairment in oxalate homeostasis can trigger localized and systemic inflammation, progressive kidney disease and cardiovascular complications, including sudden cardiac death
With further research, GLP-1 RAs could expand the therapeutic arsenal for psychiatric care, offering new hope for conditions with limited treatment options
This approach not only helps you connect with potential patients but also builds a strong, supportive network around your storefront
Once-weekly Semaglutide in Adults with Overweight or Obesity New England Journal of Medicine 384(11) 2021PMID: 33567185 NEJM 2 Jastreboff AM, Aronne LJ, Ahmad NN, et al
Alp H, Orbak Z, Akcay F, Tan H, Aksoy H: Plasma and urine carnitine levels and carnitine supplementation in children with malnutrition